High Flow Nasal Cannula Market (By Product Type: Single heated tube, Nasal cannula, Active humidifier, and Air blender; By Application: Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart Failure, and Others; By End-user: Hospitals and clinics, Ambulatory care centers, Long-term care centers, Others; By Sales Channel: Direct Channel and Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends Analysis, Regional Outlook and Forecasts, 2021 - 2030

The global high flow nasal cannula market was valued at USD 5,431.5 million in 2020 and is predicted to reach USD 15,926.4 million by the end of 2030, representing impressive CAGR of 11.3% during the forecast period 2021 to 2030.

Crucial Factors Accountable for Market Growth Are:

  • Growing incidences of asthma and COPD across the globe
  • Low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems
  • Growing geriatric population
  • Launch of advanced products by key operating players in the target industry

Key Market Insights:

Emerging applications of high flow nasal cannula are anticipated to create potential opportunities for the key players operating in global market. Due to outbreak of COVID-19, usage of high flow nasal cannula has been increased and has created tremendous opportunities for the major companies worldwide. Major players in the global market are focusing on the development of cost-effective advanced products to enhance market position. Increasing popularity and uptake of heated humidified high-flow nasal cannulas is key factor to propel industry growth over the forecast period 2021-2030. Further, ever-increasing number of respiratory disorders is growing at an alarming rate and in order treat such diseases adoption of high flow nasal cannula will continue to increase over next few years.

COVID-19 Impact on Global High Flow Nasal Cannula Market

Outbreak of COVID-19 has affected most of industries operating across the globe, however COVID-19 is projected to have positive impact on the target market as the use of high flow nasal cannula is finding special significance. The outbreak of COVID-19 has forced the key operating players to launch innovative products. The centers for disease control and prevention have acknowledged oxygenation therapy by high flow nasal cannula as ideal and recommended for the treatment of COVID-19.

Future of Global High Flow Nasal Cannula Market

Usage of high flow nasal cannula has been increased, due to ongoing COVID-19 pandemic that can have positive impact on the growth of the high flow nasal cannula industry over the forecast period. Additionally, growing attractiveness and uptake of heated humidified high-flow nasal cannulas across the world will enhance the target industry growth in the near future. Due to its excellent benefits heated humidified high-flow nasal cannulas are used to treat the patients with severe COVID-19.

Segment Analysis:

Active humidifier Product Type Segment Estimated Foremost Market Stake In 2020

Active humidifier recorded the prime market share in the global high flow nasal cannula market by product type in 2020. Increased adoption of active humidifier in increased as it offers heated and humidified breathing gas which preserves the viscosity of the mucus which in turn maintains the ciliary activity. Nasal cannulaproduct type segment is predictable to rise at a noteworthy CAGR during the forecast time-frame.

Acute Respiratory Disorder Segment Estimated to Hold Major Market Share over the Forecast Period

Acute respiratory disorder application is anticipated to dominate the target market by application during the forecast period 2021-2030. Growing demand for high flow nasal cannula in order to treat acute respiratory disorders worldwide is propelling growth of the segment.  Acute respiratory failure (ARF) is a critical condition HFNC therapy to the patients in the helps to decrease the intubation rate and increase the patient’s comfort level. However, chronic respiratory disorder segment is expected to rise at a significant CAGR during the forecast time-frame.

Hospitals and Clinics Segment is Predictable to Dominate the End-user Segment of High Flow Nasal Cannula Market Revenue

On the basis of end-user segment the global market is segregated intohospitals and clinics, long-term care centers, ambulatory care centers and others. Hospitals and clinics end-user segment is expected to dominate in terms of revenue over the forecast time frame. Ambulatory care centers end-user segment will expand at a significant CAGR during the forecast time-frame. The growth is attributed to owing to increasing demand for modern healthcare facilities that do not require overnight stay in developed countries across the globe which is in tern fueling growth of the segment.

Distribution Channel Segment is expected to Dominate the Sales Channel Segment of High Flow Nasal Cannula Market Revenue

On the basis of sales channel segment, the distribution channel end-user segment is expected to dominate in terms of revenue over the forecast time frame. Direct distribution sales channel segment will expand at a noteworthy CAGR during the forecast time-frame.

North America is estimated to be the Largest Market for High Flow Nasal Cannula

The research report covers key trends and prospects of high flow nasal cannula products across different geographical regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Geographically, high flow nasal cannula market is conquered by North America owing to increasing prevalence of COVID-19, coupled with presence of key player in the countries of the region. Further, high prevalence of respiratory diseases as well as well-established healthcare facilities United States, Canada will augment target market industry in future. Asia Pacific is expected to register the fast growth rate, on account of expanding high flow nasal cannula manufacturing capacity, coupled with presence of leading companies in the countries of Asia Pacific.

Top players contending in the market:

The companies focusing on research and development are expected to lead the global high flow nasal cannula market. Leading competitors contending in global high flow nasal cannula market are as follows:

  • Armstrong Medical Ltd
  • Salter Labs Inc
  • ResMed, Inc.
  • Teleflex Inc
  • Vapotherm Inc.
  • Becton Dickinson, and Company
  • Smiths Medical
  • Flexicare Medical Ltd
  • Teijin Pharma Limited
  • TNI Medical AG
  • Fisher & Paykel Healthcare Limited
  • Hamilton Medical AG

In order to better recognize the current status of high flow nasal cannula, and policies adopted by the foremost countries, Precedence Research predicted the future evolution of the high flow nasal cannula market. Research study offers key insights on high flow nasal cannula market and research analysis of market size and trend for probable global market segments.

Key Market Developments:

  • In May 2017, Fisher & Paykel Healthcare Corporation Ltd.launchednew infant cannula range F&P Optiflow Junior 2 used for nasal high flow therapy.
  • In October 2016, Fisher & Paykel Healthcare announced new research on the benefits of its Optiflow nasal high flow therapy.

Major Market Segments Covered:

By Product Type

  • Single heated tube
  • Nasal cannula
  • Active humidifier
  • Air blender

By Application

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease
  • Acute Heart Failure
  • Others

By End-user

  • Hospitals and clinics
  • Ambulatory care centers
  • Long-term care centers
  • Others

By Sales Channel

  • Direct Channel
  • Distribution Channel

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa
Request for Customize Report
Precedence offers custom market research services that help clients to get information on their business scenario required.

FAQ's

What is Nasal Cannula System?
The Nasal Cannula (NC) is a system used to provide extra oxygen to a patient or adult in need of respiratory assistance. The nasal cannula contains a lightweight tube, which then divides into two prongs, these separate prongs are placed in the patients' nostrils, from which a mixture of air and oxygen flows.
The global high flow nasal cannula market size was valued at USD 5,431.5 million in 2020 and is predicted to reach USD 15,926.4 million by the end of 2030.
The global high flow nasal cannula market is expected to grow at a CAGR of 11.3% between forecast period 2021 to 2030.
The global high flow nasal cannula market growth is driven by growing incidences of asthma and COPD across the globe, low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems, growing geriatric population and launch of advanced products by key operating players in the target industry.
Acute respiratory disorder application is anticipated to dominate the target market by application during the forecast period 2021-2030. Growing demand for high flow nasal cannula in order to treat acute respiratory disorders worldwide is propelling growth of the segment.
North America dominated the global market with a market share of more than 40%, in 2020. The growth of the region primarily attributed to increasing prevalence of COVID-19, coupled with presence of key players in the region.
Asia Pacific is expected to register significant market share over the forecasted period owing to increase in awareness regarding the effectiveness offered by high flow nasal cannula in the countries especially in the China, India, Japan, Thailand in the in the region.
The major companies functioning in the worldwide high flow nasal cannula market include Armstrong Medical Ltd, Salter Labs Inc, ResMed, Inc. Teleflex Inc, Vapotherm Inc. Becton Dickinson, and Company, Smiths Medical, Flexicare Medical Ltd, Teijin Pharma Limited. TNI Medical AG, Fisher & Paykel Healthcare Limited, and Hamilton Medical AG among others.

PROCEED TO BUY

   USD 4999
   USD 7999

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence client

Get a Sample
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com